Skip to main content
Top

08-08-2022 | Insulin | News

News in brief

Daily insulin dose may be linked to cancer risk in type 1 diabetes

Author: Claire Barnard

print
PRINT
insite
SEARCH

medwireNews: People with type 1 diabetes who take a higher daily dose of insulin may have an increased risk for cancer compared with those on lower doses, US researchers report.

In their analysis of 1303 individuals with type 1 diabetes from the DCCT/EDIC cohort, 7% of whom developed cancer over 28 years of follow-up, the investigators found that the incidence of cancer per 1000 person–years was highest in people with a high average daily dose of insulin (≥0.8 units/kg), at 2.91. This decreased to 2.87 in those taking a medium daily dose (0.5 to <0.8 units/kg), and fell further, to 2.11, in those with a low daily dose (<0.5 units/kg).

Each unit/kg increase in daily insulin dose was associated with a significant 5.93-fold increased risk for cancer in a multivariable analysis model including time-dependent variables, and a 4.13-fold increased risk in a model including time-fixed variables. Women also had a significantly higher cancer risk than men, as did older versus younger people.

Wenjun Zhong (Merck & Co Inc, West Point, Pennsylvania) and Yuanjie Mao (Ohio University, Athens) caution that their study did not demonstrate a causal association and was limited by small participant numbers, “which precluded analyses with specific cancer types and resulted in a wide [confidence interval] for daily insulin dose.”

They conclude in a letter to JAMA Oncology that “larger studies in [type 1 diabetes] are needed to validate this association.”

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group

JAMA Oncol 2022; doi:10.1001/jamaoncol.2022.2960


print
PRINT

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »